ONC Q3 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q3 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$206M+126.7% YoY

Gross Profit

$159M77.0% margin

Operating Income

-$462M-224.0% margin

Net Income

-$438M-212.2% margin

EPS (Diluted)

$-4.42

QoQ Revenue Growth

+37.6%

Cash Flow

Operating Cash Flow

-$496M

Free Cash Flow

-$563M

Stock-Based Comp.

$67M

Balance Sheet

Total Assets

$5.3B

Total Liabilities

$1.9B

Stockholders' Equity

$3.4B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$206M	$91M	+126.7%
Gross Profit	$159M	$70M	+127.3%
Operating Income	-$462M	-$440M	-5.0%
Net Income	-$438M	-$425M	-3.0%